Status:
WITHDRAWN
Nitropaste in Breast Reduction
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Conditions:
Gynecomastia
Delayed Wound Healing
Eligibility:
FEMALE
18-64 years
Phase:
PHASE3
Brief Summary
The purpose of this study is evaluate the effect of Nitroglycerin paste on wound healing and scarring. Previous research has shown that Nitroglycerin paste can improve the blood flow to a wound, which...
Detailed Description
This will be a single-center, patient-blinded, (breast) randomized trial utilizing nitroglycerin paste on their breast reduction scar. The study team aims to randomize 100 patients, or 200 breasts. Ea...
Eligibility Criteria
Inclusion
- Patients who are female and transmen
- Undergoing bilateral breast reduction via Mount Sinai Plastic Surgery Clinic
- Reduction must be performed via Wise incisional pattern
Exclusion
- Patients who are male or transwomen
- Patients who are under 18 years of age
Key Trial Info
Start Date :
August 20 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04321967
Start Date
August 20 2019
End Date
November 1 2022
Last Update
November 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai Hospital
New York, New York, United States, 10029